Drug profile · INN
aprepitant
EMEND
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
aprepitant (EMEND) is an FDA-listed pharmaceutical active ingredient. Associated with Heron Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12290520
Methods of use of emulsion formulations of aprepitant
granted -
US 12144815
Use of aprepitant for treating Alzheimer's disease
granted -
US 10953018
Emulsion formulations of aprepitant
granted -
US 10500208
Emulsion formulations of aprepitant
granted -
US 9974794
Emulsion formulations of aprepitant
granted -
US 9974793
Emulsion formulations of aprepitant
granted -
US 9808465
Emulsion formulations of aprepitant
granted -
US 9561229
Emulsion formulations of aprepitant
granted
Frequently asked questions
What is aprepitant?
aprepitant (EMEND) is an FDA-listed pharmaceutical active ingredient. Associated with Heron Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aprepitant?
EMEND is a marketed brand name for aprepitant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aprepitant?
aprepitant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.